Literature DB >> 19078747

Frequency of anxiety in myasthenia gravis.

Jessica Lundeen1, Justin Fisher, Milind J Kothari.   

Abstract

Symptoms of anxiety are common in many chronic medical conditions. Myasthenia gravis (MG) is a chronic neuromuscular condition characterized by fatigable weakness; few studies to date have examined the occurrence of anxiety in patients with MG and related it to anxiety in other chronic conditions. Sixty-nine patients were given a set of self-administered questionnaires, which included the Beck Anxiety Inventory (BAI). The BAI was scored and showed that 55% of the patients had scores suggestive of anxiety. Forty percent was mildly anxious, 12% were moderately anxious, and 3% were severely anxious. This study suggests that anxiety is at least as common in patients with MG as in patients with other chronic medical conditions. It also suggests that the BAI is a clinically useful tool for assessing anxiety in such a population.

Entities:  

Year:  2004        PMID: 19078747     DOI: 10.1097/01.cnd.0000138445.13978.e4

Source DB:  PubMed          Journal:  J Clin Neuromuscul Dis        ISSN: 1522-0443


  4 in total

1.  Psychosocial aspects in myasthenic patients treated by plasmapheresis.

Authors:  Yu-Tai Chen; Yuanmay Chang; Hou-Chang Chiu; Jiann-Horng Yeh
Journal:  J Neurol       Date:  2011-02-02       Impact factor: 4.849

2.  The use of a trained dog as a gait aid for clients with ataxia: a case report.

Authors:  Gabriela Abbud; Caroline Janelle; Maria Vocos
Journal:  Physiother Can       Date:  2014       Impact factor: 1.037

3.  Total drug treatment and comorbidity in myasthenia gravis: a population-based cohort study.

Authors:  J B Andersen; J F Owe; A Engeland; N E Gilhus
Journal:  Eur J Neurol       Date:  2014-04-09       Impact factor: 6.089

4.  Preoperative Anxiety in Patients With Myasthenia Gravis and Risk for Myasthenic Crisis After Extended Transsternal Thymectomy: A CONSORT Study.

Authors:  Jianyong Zou; Chunhua Su; Xueping Lun; Weibing Liu; Weiling Yang; Beilong Zhong; Haoshuai Zhu; Yiyan Lei; Honghe Luo; Zhenguang Chen
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.